From Acadia, Under New CEO, Seeks Approval for Parkinson’s Drug:

Acadia CEO Steve_Davis 2015
Acadia CEO Steve_Davis 2015

Acadia Pharmaceuticals CEO Steve Davis (photo used with permission)